SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.200+2.6%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who started this subject10/15/2003 9:05:00 AM
From: nigel bates  Read Replies (1) of 3576
 
MENLO PARK, Calif.--(BUSINESS WIRE)--Oct. 15, 2003--Geron Corporation (Nasdaq: GERN - News) today announced its plans to publicly offer five million shares of its common stock in an offering made from a shelf registration statement that became effective in February 2002.

UBS Securities LLC is acting as the sole book running manager in this offering. SG Cowen Securities Corporation, Lazard and Needham & Company, Inc. are acting as co-managers. Geron would also grant to the underwriters an option to purchase an additional 750,000 shares of common stock to cover over-allotments...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext